{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:21:43Z","timestamp":1780730503359,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0012593","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000}}],"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1191368"],"award-info":[{"award-number":["GNT1191368"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2009548"],"award-info":[{"award-number":["GNT2009548"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2016396"],"award-info":[{"award-number":["GNT2016396"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203132 and 221719"],"award-info":[{"award-number":["203132 and 221719"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec030\">\n<jats:title>Background<\/jats:title>\n<jats:p>Infection with <jats:italic>Mycobacterium ulcerans<\/jats:italic> causes slowly progressive skin lesions known as Buruli ulcer (BU). An <jats:italic>M. ulcerans<\/jats:italic> controlled human infection model (MuCHIM) is likely to accelerate our understanding of this otherwise neglected disease, and may be an efficient platform for testing vaccines and other interventions. The aim of this study was to understand perceptions of this model across a range of key stakeholders in an endemic Australian community setting.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec031\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We recruited young adults who live near an Australian BU endemic area but without a personal history of BU, clinicians involved in the management of BU, young adults with a personal history of a small, treated BU, and participants of any age with a demonstrated interest in public advocacy related to their personal BU lived experience. Participants reviewed an abridged version of the provisional protocol. A series of three focus groups were then conducted by video, and the transcribed text was analysed using reflexive thematic analysis to generate themes for exploration.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec032\">\n<jats:title>Results<\/jats:title>\n<jats:p>Participants universally valued the outcomes that MuCHIM might deliver. The predominant theme was that informed consent required fully transparent communication with potential participants regarding what their participation would involve, how it would impact their lives, and both the expected outcome and \u2018worst-case scenario\u2019. They also offered actionable recommendations on how best to communicate the tension between the expected outcome and the \u2018worst-case scenario\u2019 of disease associated with delayed diagnosis and comorbidity, as typically portrayed by the media. Participants recommended including images and testimonials from people who have had BU to support the conditions for informed consent. Focus groups also gave a clear sense of who they believed would volunteer for this type of research.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec033\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This study offers valuable guidance regarding the content and presentation of information to inform potential participants, with focus group participants suggesting a multimodal approach of communication, including lived experience testimonials and clinical images of the expected outcome. This information will inform development of materials for enrolment to adequately communicate risks and expectations to potential study participants.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0012593","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:41:02Z","timestamp":1738780862000},"page":"e0012593","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Perceptions of a Buruli ulcer controlled human infection model: How, who, and why?"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-8199","authenticated-orcid":true,"given":"Stephen","family":"Muhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D. R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euzebiusz","family":"Jamrozik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Osowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Stinear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"9","key":"pntd.0012593.ref001","doi-asserted-by":"crossref","first-page":"671","DOI":"10.31128\/AJGP-08-23-6914","article-title":"An overview of Buruli ulcer in Australia","volume":"53","author":"CCW Wong","year":"2024","journal-title":"Aust J Gen Pract"},{"issue":"6","key":"pntd.0012593.ref002","doi-asserted-by":"crossref","first-page":"e0011394","DOI":"10.1371\/journal.pntd.0011394","article-title":"A human model of Buruli ulcer: the case for controlled human infection and considerations for selecting a Mycobacterium ulcerans challenge strain","volume":"17","author":"S Muhi","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0012593.ref003","doi-asserted-by":"crossref","first-page":"e0011979","DOI":"10.1371\/journal.pntd.0011979","article-title":"Mycobacterium ulcerans challenge strain selection for a Buruli ulcer controlled human infection model","volume":"18","author":"S Muhi","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"issue":"50","key":"pntd.0012593.ref004","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2021.05.092","article-title":"Systematic review of M. bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis","volume":"39","author":"S Muhi","year":"2021","journal-title":"Vaccine"},{"issue":"12","key":"pntd.0012593.ref005","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1016\/S1473-3099(23)00294-3","article-title":"Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy","volume":"23","author":"YN Abo","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"pntd.0012593.ref006","doi-asserted-by":"crossref","first-page":"k4738","DOI":"10.1136\/bmj.k4738","article-title":"Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis","volume":"363","author":"JC Crocker","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"pntd.0012593.ref007","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jep.12805","article-title":"Patient and public involvement in the design of clinical trials: an overview of systematic reviews","volume":"24","author":"A Price","year":"2018","journal-title":"J Eval Clin Pract"},{"key":"pntd.0012593.ref008","doi-asserted-by":"crossref","first-page":"793913","DOI":"10.3389\/fpubh.2022.793913","article-title":"Undertaking community engagement for a controlled human malaria infection study in Kenya: approaches and lessons learnt","volume":"10","author":"N Mumba","year":"2022","journal-title":"Front Public Health"},{"issue":"4","key":"pntd.0012593.ref009","doi-asserted-by":"crossref","first-page":"296","DOI":"10.20529\/IJME.2018.087","article-title":"Public engagement in the context of a CHIM study","volume":"3","author":"M Vaz","year":"2018","journal-title":"Indian J Med Ethics"},{"issue":"1","key":"pntd.0012593.ref010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40900-021-00277-y","article-title":"Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasis","volume":"7","author":"V Parkash","year":"2021","journal-title":"Res Involv Engagem"},{"issue":"4","key":"pntd.0012593.ref011","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.vaccine.2020.10.075","article-title":"Key criteria for the ethical acceptability of COVID-19 human challenge studies: report of a WHO Working Group","volume":"39","author":"E Jamrozik","year":"2021","journal-title":"Vaccine"},{"key":"pntd.0012593.ref012","year":"2016"},{"key":"pntd.0012593.ref013","year":"2019"},{"issue":"1","key":"pntd.0012593.ref014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1525822X16639015","article-title":"How many focus groups are enough? Building an evidence base for nonprobability sample sizes","volume":"29","author":"G Guest","year":"2016","journal-title":"Field Methods"},{"issue":"11","key":"pntd.0012593.ref015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3109\/0142159X.2014.917165","article-title":"Using focus groups in medical education research: AMEE Guide No. 91","volume":"36","author":"RE Stalmeijer","year":"2014","journal-title":"Med Teach"},{"issue":"2","key":"pntd.0012593.ref016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"V Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"4","key":"pntd.0012593.ref017","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","article-title":"Reflecting on reflexive thematic analysis","volume":"11","author":"V Braun","year":"2019","journal-title":"Qualitative Research in Sport, Exercise and Health"},{"issue":"1","key":"pntd.0012593.ref018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1037\/qup0000196","article-title":"Conceptual and design thinking for thematic analysis","volume":"9","author":"V Braun","year":"2022","journal-title":"Qual Psychol"},{"issue":"1","key":"pntd.0012593.ref019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12916-020-01670-2","article-title":"Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation","volume":"18","author":"D Gbesemete","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"pntd.0012593.ref020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/0272989X0102100108","article-title":"The inclusion of patient testimonials in decision aids","volume":"21","author":"PA Ubel","year":"2001","journal-title":"Med Decis Mak"},{"issue":"5","key":"pntd.0012593.ref021","first-page":"CD003717","article-title":"Audio-visual presentation of information for informed consent for participation in clinical trials","author":"A Synnot","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"pntd.0012593.ref022","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bmjqs-2017-006954","article-title":"Role of patient and public involvement in implementation research: a consensus study","volume":"27","author":"KA Gray-Burrows","year":"2018","journal-title":"BMJ Qual Saf"},{"issue":"9","key":"pntd.0012593.ref023","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/medethics-2019-106001","article-title":"Human infection challenge studies in endemic settings and\/or low-income and middle-income countries: key points of ethical consensus and controversy","volume":"46","author":"E Jamrozik","year":"2020","journal-title":"J Med Ethics"},{"issue":"7","key":"pntd.0012593.ref024","doi-asserted-by":"crossref","first-page":"e033796","DOI":"10.1136\/bmjopen-2019-033796","article-title":"Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials","volume":"10","author":"M-A Hoogerwerf","year":"2020","journal-title":"BMJ Open"},{"key":"pntd.0012593.ref025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.12688\/wellcomeopenres.15469.1","article-title":"Factors influencing participation in controlled human infection models: a pooled analysis from six enteric fever studies","volume":"4","author":"B Oguti","year":"2019","journal-title":"Wellcome Open Res"},{"issue":"1","key":"pntd.0012593.ref026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1556264618820219","article-title":"Exploring ethical concerns about human challenge studies: a qualitative study of controlled human malaria infection study participants\u2019 motivations and attitudes","volume":"14","author":"SA Kraft","year":"2019","journal-title":"J Empir Res Hum Res Ethics"},{"key":"pntd.0012593.ref027","doi-asserted-by":"crossref","first-page":"101747","DOI":"10.1016\/j.biologicals.2024.101747","article-title":"Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023","volume":"85","author":"M Kapulu","year":"2024","journal-title":"Biologicals"},{"issue":"8","key":"pntd.0012593.ref028","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/bioe.12802","article-title":"Ethical issues surrounding controlled human infection challenge studies in endemic low-and middle-income countries","volume":"34","author":"E Jamrozik","year":"2020","journal-title":"Bioethics"},{"key":"pntd.0012593.ref029","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-41480-1","volume-title":"Human challenge studies in endemic settings, ethical and regulatory issues","author":"E Jamrozik","year":"2021"},{"issue":"1","key":"pntd.0012593.ref030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s40592-020-00121-1","article-title":"Public perceptions on Controlled Human Infection Model (CHIM) studies-a qualitative pilot study from South India","volume":"39","author":"M Vaz","year":"2021","journal-title":"Monash Bioeth Rev"},{"issue":"1","key":"pntd.0012593.ref031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/26895269.2022.2129597","article-title":"Toward good practice in thematic analysis: avoiding common problems and be(com)ing a knowing researcher","volume":"24","author":"V Braun","year":"2022","journal-title":"Int J Transgend Health"},{"key":"pntd.0012593.ref032","doi-asserted-by":"crossref","first-page":"488","DOI":"10.12688\/wellcomeopenres.22719.1","article-title":"A human model of Buruli ulcer: provisional protocol for a Mycobacterium ulcerans controlled human infection study","volume":"9","author":"S Muhi","year":"2024","journal-title":"Wellcome Open Res"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0012593","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T18:50:43Z","timestamp":1739386243000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012593"}},"subtitle":[],"editor":[{"given":"Joseph M.","family":"Vinetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0012593","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0012593","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}